Table 5 Prognostic factors
From: Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma
Prognostic factor | 10-year LRFS (%) | 10-year DMFS (%) | 10-year PFS (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Yes | No | p | Yes | No | p | Yes | No | p | |
Male | 90.8 | 100 | 0.838 | 100 | 0.00 | 0.000 | 90.8 | 0.0 | 0.002 |
Age, < 18 years | 75.0 | 95.2 | 0.251 | 100 | 94.1 | 0.628 | 75.0 | 85.3 | 0.943 |
Symptoms | 89.5 | 100 | 0.569 | 94.4 | 100 | 0.683 | 84.2 | 100 | 0.801 |
SVCS | 100 | 84.8 | 0.238 | 100 | 92.3 | 0.433 | 100 | 77.8 | 0.011 |
Alcohol use | 90.8 | 100 | 0.838 | 95.2 | 100 | – | 86.3 | 100 | 0.838 |
Smoking | 100 | 88.7 | 0.472 | 100 | 94.1 | 0.628 | 100 | 83.0 | 0.620 |
GVI | 93.3 | 83.3 | 0.352 | 100 | 83.3 | 0.114 | 93.3 | 66.7 | 0.307 |
Diameter, > 10 cm | 100 | 83.6 | 0.194 | 90.0 | 100 | 0.294 | 90.0 | 83.6 | 0.407 |
LNM | 100 | 88.1 | 0.419 | 80.0 | 100 | 0.704 | 80.0 | 88.1 | 0.602 |
DMPD | 100 | 90.3 | 0.706 | 50.0 | 100 | 0.002 | 50.0 | 90.3 | 0.097 |
Masaoka stage III–IV | 90.0 | 100 | 0.651 | 94.7 | 100 | 0.746 | 87.0 | 100 | 0.574 |
R0 resection | 100 | 86.3 | 0.305 | 87.5 | 100 | 0.202 | 87.5 | 86.3 | 0.715 |
Radiotherapy | 93.3 | 87.5 | 0.797 | 92.3 | 100 | 0.433 | 85.6 | 87.5 | 0.236 |
Chemotherapy | 90.5 | 100 | 0.755 | 95.0 | 100 | 0.823 | 100 | 85.7 | 0.188 |